ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 2 filers reported holding ARRAY BIOPHARMA INC in Q2 2012. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2013 | $90,000 | +32.4% | 19,800 | +54.7% | 0.00% | +100.0% |
| Q1 2013 | $68,000 | -43.3% | 12,800 | -62.9% | 0.00% | -66.7% |
| Q2 2012 | $120,000 | +2.6% | 34,500 | 0.0% | 0.00% | 0.0% |
| Q1 2012 | $117,000 | +50.0% | 34,500 | -4.7% | 0.00% | +50.0% |
| Q4 2011 | $78,000 | +9.9% | 36,200 | 0.0% | 0.00% | 0.0% |
| Q3 2011 | $71,000 | – | 36,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,459,128 | $234,543,000 | 9.43% |
| APIS CAPITAL ADVISORS, LLC | 490,000 | $6,983,000 | 9.36% |
| BVF INC/IL | 4,744,062 | $67,603,000 | 8.84% |
| First Light Asset Management, LLC | 2,853,826 | $40,667,000 | 6.48% |
| SECTORAL ASSET MANAGEMENT INC | 2,165,767 | $30,862,000 | 4.20% |
| GREAT POINT PARTNERS LLC | 1,850,000 | $26,363,000 | 3.33% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 146,952 | $2,092,000 | 2.46% |
| Birchview Capital, LP | 168,000 | $2,394,000 | 2.26% |
| X-Square Capital, LLC | 180,554 | $2,572,000 | 2.02% |
| FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD | 295,610 | $4,212,000 | 1.54% |